Project Details
Description
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
| Status | Active |
|---|---|
| Effective start/end date | 9/1/25 → 8/31/27 |
Funding
- CHILDRENS TUMOR FDN
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.